New combo therapy for rare lung cancer shows promise in small trial
NCT ID NCT04028570
First seen Mar 15, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study is for people with malignant pleural mesothelioma, a rare cancer of the lung lining. It tests a new approach that combines a special type of radiation (boost radiation) with surgery to remove the affected tissue. The main goal is to find the safest radiation dose that does not cause severe lung injury. The study involves 15 participants and tracks side effects, quality of life, and pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIOMA; LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Margaret Hospital, University Health Network
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.